NYNelli Yildirimyan

Nelli Yildirimyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nelli Yildirimyan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Low salivary pH reflects high dental anxiety: evidence from a preliminary cross-sectional study

    by Ayse Tas, Nelli Agbulut

    Dental anxiety is a prevalent psychological condition that adversely affects oral health behaviors. Although physiological markers such as salivary cortisol have been explored, the potential role of salivary pH remains under-investigated. This preliminary observational study aimed to examine the association between resting salivary pH and dental anxiety levels in a healthy adult population. Forty adults (28 females, 12 males; aged 18–65 years) participated. Dental anxiety was assessed using the Modified Corah Dental Anxiety Scale (MCDAS). Resting unstimulated saliva samples were collected under standardized conditions, and pH was measured using pH indicator strips. Statistical analyses included Pearson’s correlation and ordinal regression to evaluate the association between pH and anxiety scores. The mean salivary pH was 6.19 ± 0.62, while the mean dental anxiety score was 9.18 ± 3.39. A moderate, statistically significant negative correlation was found between salivary pH and dental anxiety (r = – 0.320, p = 0.022). Ordinal regression analysis indicated a negative, though not statistically significant, predictive effect of pH on anxiety levels (β = –0.768, p = 0.144). These preliminary findings suggest that salivary pH, as a rapid, simple, and noninvasive parameter, may have adjunctive value in dental anxiety screening protocols. Its incorporation into routine chairside assessments may facilitate the early identification of at-risk patients and enhance individualized care. Further research with larger cohorts is warranted to validate these findings.

  • Open Access

    Can CAPRIN-1 Be Responsible for the Recurrence Potential of Odontogenic Keratocysts?

    by Nelli Yildirimyan, Mehmet Ali Altay, İrem Hicran Özbudak

    The purpose of this retrospective study is to compare dentigerous cysts and odontogenic keratocysts for cytoplasmic activation/proliferation - associated protein-1 antibodies via immunohistochemical staining to obtain a new perspective about the specific behavioural characteristics of odontogenic keratocysts at the molecular level.

  • Open Access

    Daha Önce Tanı Almamış İnsan İmmünyetmezlik Virüsü Pozitif Hastada Plazmablastik Lenfoma: Bir Olgu Sunumu

    by Nelli Yildirimyan, Ayşe TAŞ, Selmi Yilmaz, Mehmet Ali Altay

    Plasmablastic lymphoma (PBL) is a rare and aggressive non-Hodgkin lymphoma subtype associated with human immunodeficiency virus (HIV) infection. PBL is extremely aggressive and has a poor response to treatment. Clinically PBL resembles a periodontal disease, Kaposi sarcoma, or melanoma. Delayed diagnosis adversely affects the treatment and life expectancy. A 52-year-old male presented with a firm intraoral mass causing a slight elevation noticeable extraorally. Radiologically, loss of lamina dura around the first premolar and loss of both vertical and horizontal bone height around the dental implant replacing the second premolar were present. The biopsy confirmed a diagnosis of PBL. Further evaluation revealed that the patient was positive for HIV. The chemotherapy regimen included etoposide, vincristine, hydroxydaunorubicin, cyclophosphamide, and prednisolone, followed by an autologous hematopoietic stem cell bone marrow transplant. This article attempts to describe the clinical presentation and histopathological evaluation of PBL, and emphasize the paramount role of biopsy, early clinical suspicion, and correct diagnosis.

  • Open Access

    What is the Impact of Implant-supported Mandibular Overdentures on Oral Health-Related Quality of Life? A Retrospective Study

    by Mehmet Ali Altay, Mehmet Mustafa Ozarslan, Nelli Yildirimyan, Alper Si̇ndel

    Objective: Oral health-related quality of life (QoL) is significantly influenced by the type of the prostheses that is used for prosthetic rehabilitation of patients with complete edentulism. This study aims to retrospectively evaluate the outcomes of mandibular implant-supported overdentures (MODs) through patients’ perceptions by analyzing the results from OHIP-14 index.Methods: Relationships between OHIP-14 scores, and clinical and patient-based findings are investigated.Results: Forty-seven patients were included in the study. OHIP-14 scores ranged from 0 to 35, with a mean score of 5.81 (±6.89), indicating an overall “very high” quality of life. Patients with “very high” QoL had significantly lower pain scores than those with both “high” and “low” QoL (p=0.000, p=0.036 respectively). Further analysis revealed a positive correlation between total OHIP points and pain level (r= 0.738, p=0.000).Conclusion: Within the limitations of this study, it can be concluded that patients with complete edentulism of the mandible can effectively be rehabilitated with two implant-supported mandibular overdentures and be provided with a “very high” oral health-related QoL.


  • Open Access

    Proton pump inhibitor intake negatively affects the osseointegration of dental implants: a retrospective study

    by Mehmet Ali Altay, Alper Sindel, Öznur Özalp, Nelli Yıldırımyan, Burak Kocabalkan

    Altay MA, et al. J Korean Assoc Oral Maxillofac Surg. 2019 Jun;45(3):135-140. https://doi.org/10.5125/jkaoms.2019.45.3.135


  • Medication-related osteonecrosis of the jaw: An institution’s experience

    by Mehmet Ali Altay, Alexandra Radu, Sean E. Pack, Nelli Yıldırımyan, Andres Flores-Hidalgo, Dale A. Baur, Faisal A. Quereshy

    Objectives: This study aimed to evaluate and report the outcomes associated with the management of patients who were treated surgically for medication-related osteonecrosis of the jaw (MRONJ).Methods: Demographic and medical profiles of patients with a diagnosis of MRONJ were created. The type of surgical treatment, complications, and treatment outcomes were identified.Results: Twenty-one patients with an average age of 68.42 years (range 40–90 years) were included. Nineteen patients had only mandible involvement, one patient had only maxilla involvement, and one patient had both mandible and maxilla involvement. Thirteen patients underwent marginal resections. Eight patients underwent segmental resection of the mandible with immediate reconstruction. Nineteen patients healed without any complications. Two patients who had undergone segmental resection of the mandible experienced postoperative complications and needed a second surgery to achieve primary closure.Discussion: Advanced MRONJ can effectively be treated with resective surgery in combination with medical treatment.


  • Does the Intake of Selective Serotonin Reuptake Inhibitors Negatively Affect Dental Implant Osseointegration? A Retrospective Study

    by Mehmet Ali Altay, Alper Sindel, Öznur Özalp, Nelli Yildirimyan, Dinçer Kader, Uğur Bilge, Dale A. Baur

    The success of osseointegration is influenced by several factors that affect bone metabolism and by certain systemic medications. Selective serotonin reuptake inhibitors (SSRIs) have been previously suggested to be among these medications. This study aims to investigate the association between systemic intake of SSRIs and failure of osseointegration in patients rehabilitated with dental implants. A retrospective cohort study was conducted, including a total of 2055 osseointegrated dental implants in 631 patients (109 implants in 36 SSRI \users and 1946 in 595 nonusers). Predictor and outcome variables were SSRI intake and osseointegration failure, respectively. The data were analyzed with Mann–Whitney test or Fisher exact test accordingly. Both patient-level and implant-level models were implemented to evaluate the effect of SSRI exposure on the success of osseointegration of dental implants. Median duration of follow-up was 21.5 months (range = 4–56 months) for SSRI users and 23 months (range –60 months) for nonusers (P = .158). Two of 36 SSRI users had 1 failed implant each; thus, the failure rate was 5.6%. Eleven nonusers also had 1 failed implant each; thus, the failure rate was 1.85%. The difference between the 2 groups failed to reach statistical significance at patient and implant levels (P = .166, P = .149, respectively). The odds of implant failure were 3.123 times greater for SSRI users compared with nonusers. Patients using SSRIs were found to be 3.005 times more likely to experience early implant failure than nonusers. The results of this study suggest that SSRIs may lead to increase in the rate of osseointegration failure, although not reaching statistical significance.


  • Open Access

    Comparative assessment of 3D reconstruction technique and Cavalieri’s principle in predicting the mandibular bone defect volumes

    by Mehmet Altay, Faisal Quereshy, Sumit K. Nijhawan Nijhawan, Jose F. Teppa, Michael P. Horan, Nelli Yıldırımyan, Dale Baur

    İstanbul Üniversitesi | Tarihten Geleceğe Bilim Köprüsü - 1453


  • Novel Technique for Reconstruction of the Severely Resorbed Posterior Maxillae

    by Mehmet Ali Dds Altay, Alper Dds Sindel, Nelli Dds Yildirimyan, Mehmet Mustafa Dds Özarslan

    Purpose: This report describes a novel technique that allows for 3-dimensional augmentation of localized bone defects of the posterior maxilla and simultaneous implant placement by means of using the maxillary tuberosity as a block graft. Materials and Methods: The residual bone in maxillary tuberosity is harvested as a whole. The recipient site and the bone graft are prepared with compatible implant drills. The bone graft is flipped to fit the defect and fixated in place using the dental implant, which anchors both the graft and the subantral bone. Results: The defect of the posterior maxilla is reconstructed with autogenous bone harvested from maxillary tuberosity, and simultaneous implant placement is achieved. Conclusion: The proposed technique enables the clinician to reconstruct alveolar defects of the posterior maxilla without the need for an additional donor site and simultaneously place dental implants.


  • Is History of Periodontitis a Risk Factor for Peri-implant Disease? A Pilot Study

    by Mehmet Altay, Sinan Tozoğlu, Nelli Yıldırımyan, Mehmet Özarslan

    Mehmet Ali Altay, DDS, PhD/Sinan Tozoğlu, DDS, PhD/Nelli Yıldırımyan, DDS/Mehmet Mustafa Özarslan, DDS, PhD: Purpose: The aim of this pilot study was to evaluate clinical outcomes of implant treatment in periodontally compromised patients. Materials and Methods: Partially edentulous patients who were diagnosed and treated for chronic periodontitis and later rehabilitated with implant-supported single crowns or fixed partial dentures were enrolled in this study. At the final follow-up, data on probing pocket depth and bleeding on probing were collected, and changes in peri-implant bone levels were assessed on periapical radiographs. Accordingly, patients were categorized into peri-implant disease–free (PID-free), peri-implant mucositis (PIM), or peri-implantitis (PI) groups. Additionally, information on the history of systemic diseases was obtained and correlated with the findings. Results: Seven females and six males with a mean age of 55.2 (standard deviation [SD] ± 8.38) years were included in this study. Fifty-five implants were placed in 13 partially edentulous patients with a history of chronic periodontitis. The mean follow-up in the study was 35.1 (SD ± 2.40) months. No implants were lost in the 13 patients, for a cumulative survival of 100%. PI was confirmed in 3 patients and PIM in 8 patients, while 2 patients were found to be PID-free. Diabetes and hypertension were found to be the predominant systemic factors among patients affected by peri-implant diseases. Conclusion: Patients with a history of periodontitis are at considerable risk of being affected by peri-implant mucositis, if not by peri-implantitis.